Press-release for stocks

Prices are updated after-hours

crawled time : 13:20

save search

Neovasc to Report First Quarter Financial Results on May 12, 2022
Published: 2022-04-29 (Crawled : 13:20) - globenewswire.com
NVCN | $30.03 1.66% -2.02% 0

Health Technology

| 10166.67% | O: 2289.74% H: 0.0% C: 0.0%
report results

WeTrade Group Announced a Strategic Partnership with Jiqing Bio Company, to Exclusively Sell Monkeypox Test Kits and Antigen Tests
Published: 2022-08-05 (Crawled : 13:20) - prnewswire.com
WETG | $5.05 0.4% 9.3K

| -99.85% | O: 167.76% H: 3.06% C: -57.92%
partnership monkeypox test group

LIXTE Biotechnology Announces Preclinical Results of its Collaboration with the Netherlands Cancer Institute, Revealing Striking Anti-Cancer Activity of LB-100 In Novel Drug Combinations
Published: 2022-04-12 (Crawled : 13:20) - biospace.com/
LIXT | $3.3 -1.49% -1.52% 40K

Health Technology

| 192.73% | O: 127.27% H: 98.0% C: -26.4%
lb-100 netherlands drug preclinical collaboration results cancer pre-clinical

Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer
Published: 2022-12-20 (Crawled : 13:20) - globenewswire.com
ATNX | $0.2031 -7.78% 1.9M

Health Technology

| 60.55% | O: 118.18% H: 8.7% C: -42.03%
quantum breast trial leap positive cancer

Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel
Published: 2022-12-20 (Crawled : 13:20) - biospace.com/
ATNX | $0.2031 -7.78% 1.9M

Health Technology

| 60.55% | O: 118.18% H: 8.7% C: -42.03%
quantum trial leap positive

SPYR Technologies Enters into Material Definitive Agreement to Acquire GeoTraq, Inc.
Published: 2022-05-31 (Crawled : 13:20) - globenewswire.com
SPYR | $0.0001 0.0% 2M

Accommodation and Food Services

| -99.71% | O: 8.57% H: 14.47% C: -7.89%
JAN | $4.52 4.39% 4.2% 510K

Industrial Services

| 101.34% | O: 106.25% H: 5.84% C: -19.26%

Kintara Therapeutics Enters Into Equity Purchase Agreement for Up to $20 Million with Lincoln Park Capital
Published: 2022-08-03 (Crawled : 13:20) - biospace.com/
KTRA | $0.1309 14.52% 12.68% 7.5M

Distribution Services

| -98.53% | O: 105.14% H: 10.04% C: -32.6%
therapeutics agreement

Elys Game Technology and Cloakbook DC Granted License to Open Sportsbook in Washington, D.C.
Published: 2022-12-27 (Crawled : 13:20) - globenewswire.com
ELYS | $0.1302 -2.84% 14.4% 2.5K

Consumer Services

| -25.54% | O: 102.46% H: 41.44% C: 4.67%
license technology granted

Trean Insurance Group Announces Definitive Agreement to be Acquired by Altaris Capital Partners
Published: 2022-12-16 (Crawled : 13:20) - globenewswire.com
TIG | $6.16 0.0% 6.2M

Finance

| 99.19% | O: 93.53% H: 0.0% C: 0.0%
insurance acquired group

SAB Biotherapeutics Granted Fast Track Designation from FDA for SAB-176 Influenza Immunotherapy with High Cross-Reactivity to Multiple Strains of Influenza
Published: 2023-04-13 (Crawled : 13:20) - biospace.com/
SABS | $4.39 7.54% 860

| 1047.37% | O: 81.58% H: 18.84% C: 9.99%
sab-176 fda granted influenza designation immunotherapy fast track designation

Context Therapeutics’ Clinical Partner Stemline Therapeutics, a Subsidiary of Menarini Group Receives FDA Approval of ORSERDU™ (elacestrant) in ER+, HER2-, ESR1-mutated Breast Cancer
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
CNTX | $1.41 3.68% 8.11% 24K

Health Technology

| 106.44% | O: 78.62% H: 27.05% C: -13.11%
fda breast approval cancer group elascestrant orserdu ona-xr her2- her2

IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries
Published: 2023-06-12 (Crawled : 13:20) - globenewswire.com
IRME | $0.95 108.33% 3K

| 0.0% | O: 73.68% H: 0.06% C: -69.09%
device skin

Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF)
Published: 2022-12-06 (Crawled : 13:20) - prnewswire.com
SMMT | $3.72 6.59% 6.18% 1.8M

Health Technology

| 375.16% | O: 68.15% H: 77.27% C: 75.0%
global collaboration commercialization license therapeutics agreement

Protect Pharmaceutical and Aetsoft Announce Further Details of Merger
Published: 2022-05-20 (Crawled : 13:20) - globenewswire.com
PRTT | $2.7 14.18% 6.1K

Manufacturing

| 1053.69% | O: 67.58% H: 0.0% C: -39.97%

Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-04-25 (Crawled : 13:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K

Health Technology

| -90.09% | O: 63.83% H: 12.66% C: -32.14%
bx1000 positive trial results phase 2

Trident Brands Announces Authorization of Preferred Stock to Complete Planned Debt Reduction
Published: 2022-04-04 (Crawled : 13:20) - globenewswire.com
TDNT | $0.0001 200.0% 61K

Manufacturing

| -99.73% | O: 56.33% H: 20.69% C: -16.72%
brands authorization

Doug Heldoorn, CEO of ACTX, and Shannon Illingworth, Inventor of GrowPods, Describe Future of Farming
Published: 2022-09-22 (Crawled : 13:20) - prnewswire.com
ACTX | $0.0001 249900.0% 42K

Manufacturing

| -99.98% | O: 49.63% H: 0.0% C: -25.0%
ceo

SciSparc's Drug Discovery Joint Venture MitoCareX Bio Successfully Reached First Milestone for its Future Machine Learning System
Published: 2023-02-17 (Crawled : 13:20) - globenewswire.com
SPRC | $1.225 0.41% 0.41% 110K

Manufacturing

| 35.16% | O: 46.15% H: 0.0% C: -24.81%
drug system milestone

CanAlaska Discovers Significant New Uranium Zone at West McArthur
Published: 2022-07-15 (Crawled : 13:20) - canalaska.com
CVVUF | $0.44 4.76% 2.11% 9.6K

Non-Energy Minerals

| 111.54% | O: 46.06% H: 0.0% C: -7.83%
uranium